A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic?
Gespeichert in:
| Veröffentlicht in: | Dermatologic therapy 2020-07, Vol.33 (4), p.e13383-n/a |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 4 |
| container_start_page | e13383 |
| container_title | Dermatologic therapy |
| container_volume | 33 |
| creator | Kutlu, Ömer Metin, Ahmet |
| description | |
| doi_str_mv | 10.1111/dth.13383 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7235511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DTH13383</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4103-18e1c2fca9f84661de388c6de189831cc931917f46c8c7835ec2e636a046ef643</originalsourceid><addsrcrecordid>eNp1kUlOxDAQRS0EYl5wAeQti0AqTtw2CxBqRgmJDcPSMk6FGKXjxg5D7zgCp-BgnAQ3YVzgTdmqX--79AlZg3QT4tkqu3oTGBNshixCkclEpCBn451JnqSZ5AtkKYTbNIVMMpgnCyzLCikGYpG87lGjA1JXUXzSBv217qxrp-9xcN7qYAPVVYeeuoBNp0f2wXqq25LWk9K7p4mpG-fd3b1tkdqWajqOBGw7-mi7mg7PLk_2355fQG7TK9s0H27hL962xuP0E73Pz0hEtSWOrNldIXOVbgKuftZlcnF4cD48Tk7Pjk6Ge6eJySFlCQgEk1VGy0rknEOJTAjDSwQhBQNj4voSBlXOjTADwQo0GXLGdZpzrHjOlslOzx3fX4-wNHEPrxs19nak_UQ5bdXfTmtrdeMe1CBjRQEQARs9wHgXgsfqexZSNQ1LxbDUR1hRu_7b7Fv5lU4UbPWCR9vg5H-S2j8_7pHv2tmjYw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kutlu, Ömer ; Metin, Ahmet</creator><creatorcontrib>Kutlu, Ömer ; Metin, Ahmet</creatorcontrib><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.13383</identifier><identifier>PMID: 32259878</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Aged ; Antiviral Agents - administration & dosage ; Antiviral Agents - adverse effects ; Coronavirus Infections - drug therapy ; COVID-19 ; Female ; Humans ; Hydroxychloroquine - administration & dosage ; Hydroxychloroquine - adverse effects ; Letter ; Letters ; Oseltamivir - administration & dosage ; Oseltamivir - adverse effects ; Pandemics ; Pneumonia, Viral - drug therapy ; Psoriasis - etiology ; Psoriasis - pathology</subject><ispartof>Dermatologic therapy, 2020-07, Vol.33 (4), p.e13383-n/a</ispartof><rights>2020 Wiley Periodicals LLC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4103-18e1c2fca9f84661de388c6de189831cc931917f46c8c7835ec2e636a046ef643</citedby><cites>FETCH-LOGICAL-c4103-18e1c2fca9f84661de388c6de189831cc931917f46c8c7835ec2e636a046ef643</cites><orcidid>0000-0002-9665-015X ; 0000-0002-6512-4990</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.13383$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.13383$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,778,782,883,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32259878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kutlu, Ömer</creatorcontrib><creatorcontrib>Metin, Ahmet</creatorcontrib><title>A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic?</title><title>Dermatologic therapy</title><addtitle>Dermatol Ther</addtitle><subject>Aged</subject><subject>Antiviral Agents - administration & dosage</subject><subject>Antiviral Agents - adverse effects</subject><subject>Coronavirus Infections - drug therapy</subject><subject>COVID-19</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxychloroquine - administration & dosage</subject><subject>Hydroxychloroquine - adverse effects</subject><subject>Letter</subject><subject>Letters</subject><subject>Oseltamivir - administration & dosage</subject><subject>Oseltamivir - adverse effects</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - drug therapy</subject><subject>Psoriasis - etiology</subject><subject>Psoriasis - pathology</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUlOxDAQRS0EYl5wAeQti0AqTtw2CxBqRgmJDcPSMk6FGKXjxg5D7zgCp-BgnAQ3YVzgTdmqX--79AlZg3QT4tkqu3oTGBNshixCkclEpCBn451JnqSZ5AtkKYTbNIVMMpgnCyzLCikGYpG87lGjA1JXUXzSBv217qxrp-9xcN7qYAPVVYeeuoBNp0f2wXqq25LWk9K7p4mpG-fd3b1tkdqWajqOBGw7-mi7mg7PLk_2355fQG7TK9s0H27hL962xuP0E73Pz0hEtSWOrNldIXOVbgKuftZlcnF4cD48Tk7Pjk6Ge6eJySFlCQgEk1VGy0rknEOJTAjDSwQhBQNj4voSBlXOjTADwQo0GXLGdZpzrHjOlslOzx3fX4-wNHEPrxs19nak_UQ5bdXfTmtrdeMe1CBjRQEQARs9wHgXgsfqexZSNQ1LxbDUR1hRu_7b7Fv5lU4UbPWCR9vg5H-S2j8_7pHv2tmjYw</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Kutlu, Ömer</creator><creator>Metin, Ahmet</creator><general>John Wiley & Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9665-015X</orcidid><orcidid>https://orcid.org/0000-0002-6512-4990</orcidid></search><sort><creationdate>202007</creationdate><title>A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic?</title><author>Kutlu, Ömer ; Metin, Ahmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4103-18e1c2fca9f84661de388c6de189831cc931917f46c8c7835ec2e636a046ef643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Antiviral Agents - administration & dosage</topic><topic>Antiviral Agents - adverse effects</topic><topic>Coronavirus Infections - drug therapy</topic><topic>COVID-19</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxychloroquine - administration & dosage</topic><topic>Hydroxychloroquine - adverse effects</topic><topic>Letter</topic><topic>Letters</topic><topic>Oseltamivir - administration & dosage</topic><topic>Oseltamivir - adverse effects</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - drug therapy</topic><topic>Psoriasis - etiology</topic><topic>Psoriasis - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kutlu, Ömer</creatorcontrib><creatorcontrib>Metin, Ahmet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kutlu, Ömer</au><au>Metin, Ahmet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic?</atitle><jtitle>Dermatologic therapy</jtitle><addtitle>Dermatol Ther</addtitle><date>2020-07</date><risdate>2020</risdate><volume>33</volume><issue>4</issue><spage>e13383</spage><epage>n/a</epage><pages>e13383-n/a</pages><issn>1396-0296</issn><eissn>1529-8019</eissn><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>32259878</pmid><doi>10.1111/dth.13383</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9665-015X</orcidid><orcidid>https://orcid.org/0000-0002-6512-4990</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1396-0296 |
| ispartof | Dermatologic therapy, 2020-07, Vol.33 (4), p.e13383-n/a |
| issn | 1396-0296 1529-8019 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7235511 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Aged Antiviral Agents - administration & dosage Antiviral Agents - adverse effects Coronavirus Infections - drug therapy COVID-19 Female Humans Hydroxychloroquine - administration & dosage Hydroxychloroquine - adverse effects Letter Letters Oseltamivir - administration & dosage Oseltamivir - adverse effects Pandemics Pneumonia, Viral - drug therapy Psoriasis - etiology Psoriasis - pathology |
| title | A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T04%3A42%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20exacerbation%20of%20psoriasis%20after%20oseltamivir%20and%20hydroxychloroquine%20in%20a%20patient%20with%20COVID%E2%80%9019:%20Will%20cases%20of%20psoriasis%20increase%20after%20COVID%E2%80%9019%20pandemic?&rft.jtitle=Dermatologic%20therapy&rft.au=Kutlu,%20%C3%96mer&rft.date=2020-07&rft.volume=33&rft.issue=4&rft.spage=e13383&rft.epage=n/a&rft.pages=e13383-n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.13383&rft_dat=%3Cwiley_pubme%3EDTH13383%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32259878&rfr_iscdi=true |